title: For your eyes only: Harnessing human embryonic stem cell-derived retinal pigment epithelial cells to improve impaired vision.
abstract: Vision loss or impairment resulting from the degeneration of the retinal pigment epithelium and photoreceptor death affects millions worldwide. Recent exciting results from clinical studies of small numbers of patients treated with human embryonic stem cell-derived retinal pigment epithelial cells may provide hope for affected individuals.
authors.affiliation: Department of Pathology and Laboratory Medicine, The Hospital for Sick Children, University of Toronto, Toronto, Ontario M5G 0A4, Canada.
authors.forename: Jim
authors.initials: J
authors.lastname: Hu
authors.affiliation: Molecular Oncology Laboratory, The University of Chicago Medical Center, Chicago, IL 60637, USA.
authors.forename: Tong-Chuan
authors.initials: TC
authors.lastname: He
authors.affiliation: The Editorial Office of Genes & Diseases, Chongqing, 400046, China.
authors.forename: Fei
authors.initials: F
authors.lastname: Li
keywords: Cell therapy; Human embryonic stem cell; Macular degeneration; Retinal pigment epithelium; Stargardt's disease
references.citation: Stem Cell Reports. 2015 May 12;4(5):860-72
references.pmid: 25937371
references.citation: Clin Chem Lab Med. 2011 Apr;49(4):601-16
references.pmid: 21175380
references.citation: Lancet. 2015 Feb 7;385(9967):509-16
references.pmid: 25458728
references.citation: Ophthalmology. 2012 Jun;119(6):1199-210
references.pmid: 22449572
references.citation: Chem Immunol Allergy. 2007;92:86-93
references.pmid: 17264485